About this ETF
This iShares Micro-Cap ETF endeavors to mirror the investment outcomes of a benchmark index comprising stocks from the smallest U.S. companies by market capitalization.
Description from the fund data provider · profile as of Aug 27, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +6.12% | +4.11% | +18.37% | +25.96% | +40.68% | +23.37% | +6.60% | +10.11% | +6.77% |
| Total return | +6.12% | +4.39% | +18.87% | +26.49% | +42.31% | +24.83% | +7.84% | +11.34% | +7.99% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Aug 25, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.60% | Annual cost of a $10,000 investment | $60.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Aug 26, 2026 — portfolio reporting date from the data provider; holdings are not live positions. 1361 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | SELLAS LIFE SCIENCES GROUP INC | SLS | 0.60% | 650.00K | $9.2M |
| 2 | CAREDX | CDNA | 0.59% | 176.64K | $9.0M |
| 3 | NURIX THERAPEUTICS INC | NRIX | 0.58% | 330.16K | $8.9M |
| 4 | PENGUIN SOLUTIONS INC | PENG | 0.57% | 173.45K | $8.7M |
| 5 | INTERFACE | TILE | 0.51% | 201.47K | $7.8M |
| 6 | OUSTER | OUST | 0.51% | 215.79K | $7.8M |
| 7 | VIRIDIAN THERAPEUTICS ORS INC | VRDN | 0.49% | 311.45K | $7.5M |
| 8 | MBX BIOSCIENCES | MBX | 0.48% | 106.94K | $7.3M |
| 9 | UROGEN PHARMA | URGN | 0.45% | 146.73K | $6.8M |
| 10 | BUTTERFLY NETWORK CLASS A | BFLY | 0.43% | 725.19K | $6.6M |
| 11 | INNODATA | INOD | 0.41% | 109.72K | $6.3M |
| 12 | NUVATION BIO CLASS A | NUVB | 0.40% | 867.79K | $6.2M |
| 13 | PORCH GROUP INC | PRCH | 0.38% | 336.42K | $5.9M |
| 14 | ELLINGTON FINANCIAL | EFC | 0.38% | 428.23K | $5.8M |
| 15 | ETON PHARMACEUTCIALS INC | ETON | 0.38% | 91.92K | $5.8M |
| 16 | QCR HOLDINGS INC | QCRH | 0.38% | 57.62K | $5.8M |
| 17 | DIME COMMERCIAL BANCSHARES | DCOM | 0.37% | 141.60K | $5.7M |
| 18 | TURNING POINT BRANDS INC | TPB | 0.37% | 65.48K | $5.6M |
| 19 | ORIGIN BANCORP INC | OBK | 0.36% | 104.30K | $5.5M |
| 20 | BANK FIRST CORP | BFC | 0.36% | 35.83K | $5.5M |
| 21 | BIOLIFE SOLUTIONS | BLFS | 0.36% | 146.80K | $5.5M |
| 22 | LINDBLAD EXPEDITIONS HOLDINGS | LIND | 0.36% | 171.90K | $5.5M |
| 23 | CONNECTONE BANCORP | CNOB | 0.36% | 169.83K | $5.4M |
| 24 | RAPPORT THERAPEUTICS | RAPP | 0.35% | 105.36K | $5.4M |
| 25 | XERIS BIOPHARMA HOLDINGS | XERS | 0.34% | 591.05K | $5.2M |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 0.95% | Paid (last 12 months) | $1.8902 |
| Frequency | Special | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | Jun 15, 2026 | Last payment | $0.5145 (Jun 18, 2026) |
| Growth 1Y | +35.18% | Growth 3Y / 5Y (ann.) | +10.26% / +14.73% |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Jun 15, 2026 | Jun 15, 2026 | Jun 18, 2026 | $0.5145 |
| Mar 17, 2026 | Mar 17, 2026 | Mar 20, 2026 | $0.2451 |
| Dec 16, 2025 | Dec 16, 2025 | Dec 19, 2025 | $0.7330 |
| Sep 16, 2025 | Sep 16, 2025 | Sep 19, 2025 | $0.3976 |
| Jun 16, 2025 | Jun 16, 2025 | Jun 20, 2025 | $0.3241 |
| Mar 18, 2025 | Mar 18, 2025 | Mar 21, 2025 | $0.2783 |
| Dec 17, 2024 | Dec 17, 2024 | Dec 20, 2024 | $0.3775 |
| Sep 25, 2024 | Sep 25, 2024 | Sep 30, 2024 | $0.4183 |
| Jun 11, 2024 | Jun 11, 2024 | Jun 17, 2024 | $0.3259 |
| Mar 21, 2024 | Mar 22, 2024 | Mar 27, 2024 | $0.2543 |
| Dec 20, 2023 | Dec 21, 2023 | Dec 27, 2023 | $0.3870 |
| Sep 26, 2023 | Sep 27, 2023 | Oct 02, 2023 | $0.4280 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 23.68% / 24.50% | Sharpe 1Y / 3Y | 1.81 / 1.02 |
| Max drawdown 1Y / 3Y | -12.43% / -29.46% | Sortino 1Y | 2.73 |
| Beta vs S&P 500 (3Y) | 1.20 | Correlation vs S&P 500 (1Y) | 0.764 |
| Downside deviation 1Y | 15.71% | Risk-free rate used | 3.72% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Aug 26, 2026. Formulas →
Liquidity
| Volume today | 21.44K | Average volume | 126.12K |
| AUM | $1.53B | Premium/Discount | -0.72% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | $16.7M | +1.10% | $1.51B → $1.53B |
| 1 Week | $7.5M | +0.49% | $1.52B → $1.53B |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for IWC
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.
IWC